Meet a Guru: Brittani Smith

Global Medical Device Podcast · 20 Apr 2023 · 29m · Episode 315

What this episode covers

Brittani Smith, a Medical Device Guru at Greenlight Guru, discusses her rapid career progression from regulatory coordinator to development engineering in just over two years. She emphasizes the importance of reading primary standards like ISO 13485 and 14971 to build confidence and avoid pitfalls in UDI and EU MDR implementation. Smith highlights the critical need for comprehensive documentation to prevent reliance on tribal knowledge and advises medical device professionals to assess risk and quality processes early in the design phase.

Other shows on the same ground, closest first.

  • Being an Engineer · 50m

    Etienne Nichols | How to Become a MedTech Engineer

    Etienne Nichols, Community Manager at Greenlight Guru, shares his transition from aerospace and steel manufacturing to MedTech, offering five key suggestions for engineers making a similar switch. He emphasizes reading regulations like ISO 13485 and 21 CFR Part 820 first, falling in love with the problem rather than the solution, and maintaining cross-functional relationships. Nichols also discusses the value of hands-on machining experience, the importance of curiosity in overcoming imposter syndrome, and his personal experiences with high-risk activities like skydiving.

  • Being an Engineer · 37m

    S1E12 Simplifying Quality Management | Jon Speer

    Jon Speer, founder of Greenlight Guru, explains how his frustration with managing medical device quality via Excel spreadsheets led to the creation of a dedicated QMS software platform. He details the transition from chemical engineering to medical device systems, highlighting the specific pain points of manual data merging and the high validation burden for electronic records. The episode covers Greenlight Guru’s development, its focus on design controls and traceability matrices, and the regulatory challenges of FDA submissions and ISO 13485 certification for startups.

  • Being an Engineer · 51m

    S1E13 A Holistic View on Product Development | Devon Campbell

    Devon Campbell, founder of Prodct LLC, discusses his advisory practice for early-stage biotech and medical device companies, drawing on his experience at Ventana Medical Systems, Quanterix, and Novartis. He explains how his background in machine shop operations and holistic product development—from design to field service—enabled his rapid rise to senior leadership roles. Campbell advocates for dual-career tracks in engineering, allowing brilliant technical contributors to become 'fellows' without becoming managers, and emphasizes the importance of integrating regulatory strategy (FDA, ISO 13485) from the earliest stages of product development to avoid costly rework.

  • Let's Combinate · 1h 19m

    031 - "The Five Stages Of Regulatory Grief" with Michelle Lott

    Michelle Lott, founder of Lean RAQA, discusses her journey from large manufacturer Baxter Healthcare to consulting for small-to-mid-size medical device companies, highlighting the gap in practical regulatory strategy. She details the 'five stages of regulatory grief' clients experience when facing FDA interactions, contrasting the US 510(k) process with the rigorous, ongoing costs of EU MDR compliance. Lott also explains the nuances of regulations versus guidance documents, the QMSR harmonization, and her unique perspective as an elected industry representative on the FDA Device GMP Advisory Committee.

  • Let's Combinate · 1h 31m

    025 - “The Frying Pan to the Fire” with Edwin Bills

    Edwin Bills, a Risk Management Expert and former committee member for ISO 14971, ISO TR 24971, and AAMI TIR 105, explains the evolution of risk management standards in medical devices and combination products. He details the philosophical differences between ISO 14971 and ICH Q9, emphasizing that risk management must focus on patient safety rather than just regulatory compliance. Bills advises engineers to use qualitative methods early in development and highlights the importance of analyzing interactions between drug and device constituents in combination products. He also discusses the expanded requirements for post-market surveillance in the 2019 standard and the upcoming harmonization of ISO 14971 in Europe.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.